--- title: "Weekly Recap | Lam Research -12.82%, Q2 guide misses whispers" type: "News" locale: "en" url: "https://longbridge.com/en/news/302952697.md" description: "Lam Research (LRCX) fell 12.82% this week to close at $230.10. The S&P 500 slipped 0.47% over the same period, so the stock underperformed the benchmark by about 12.35 percentage points. The week started at $275.16 on Monday, ran to a high of $279.92, then faded every session: below $270 on Tuesday, below $260 on Wednesday on heavier volume, and down to $225.14 at Friday’s low before settling at $230.10. Weekly amplitude reached 19.91%. Average daily volume of 14." datetime: "2026-10-24T06:38:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/302952697.md) - [en](https://longbridge.com/en/news/302952697.md) - [zh-HK](https://longbridge.com/zh-HK/news/302952697.md) generator: "portal-rs" --- # Weekly Recap | Lam Research -12.82%, Q2 guide misses whispers ## The Week Lam Research (LRCX) fell 12.82% this week to close at $230.10. The S&P 500 slipped 0.47% over the same period, so the stock underperformed the benchmark by about 12.35 percentage points. The week started at $275.16 on Monday, ran to a high of $279.92, then faded every session: below $270 on Tuesday, below $260 on Wednesday on heavier volume, and down to $225.14 at Friday’s low before settling at $230.10. Weekly amplitude reached 19.91%. Average daily volume of 14.0 million shares ran about 68.5% above the 60-day median of 8.31 million, marking the week as a high-volume sell-off. The Friday low of $225.14 also marked a new low in the trailing 60 sessions, versus the 6 October high of $352.56. ## Key Events The dominant story was the fiscal Q1 2027 report out after the close on 22 October and the next-quarter outlook. Revenue hit a record $8.219 billion and beat estimates, but the Q2 guide of roughly $8.6 billion came in below whispers some traders had floated. Management flagged supply bottlenecks as a cap on revenue, and attention shifted to 2027 equipment spending and gross margins. After the print, the stock slid around 8% in pre-market trading on Thursday 22 October, then widened to roughly 10% during the session; some put options jumped 620% in a day. The move was part of a broader chip sell-off: Meta fell 6% on AI spending worries, Tesla’s capital-spending cut raised demand concerns across AI chip names, and the Nasdaq lost more than 2%. Lam Research was among the hardest-hit semiconductor names on the day. ## Analyst Ratings At the latest count, 35 brokers cover Lam Research: 25 rate it buy, 4 rate it overweight, 5 rate it hold, and 1 has no opinion, with no underweight or sell ratings. The consensus rating is strong buy, and the consensus target of $364.03 sits about 58.21% above the current price of $230.10. The range is wide, from $255 to $500, pointing to meaningful disagreement about the earnings trajectory. Within the semiconductor materials and equipment industry, Lam Research ranks third out of 32 peers on broker ratings. ## The Week Ahead The next direct milestone is Lam Research’s fiscal Q2 2027 report, scheduled for 29 January 2027 after the close; the market currently models earnings per share of $2.3409 on revenue of $8.644 billion. On the macro side, 27 October brings a busy Tuesday: US durable goods orders, the ex-defence and ex-transport prints, FHFA house prices, the Case Shiller 20-city index, new home sales, the Richmond Fed composite and consumer confidence. The batch will help investors reassess manufacturing and housing momentum as well as the potential read-through for semiconductor equipment spending in a higher-rate environment. ## In Short Lam Research’s drop this week was less about fundamentals deteriorating than about elevated expectations colliding with supply constraints: a record quarter, a strong-buy consensus and a target price more than 50% above spot sat alongside a Q2 guide that missed whispers, a sector-wide pullback on AI-spending fears and a latest-session liquidity split where large lots were net sellers while smaller orders flowed in. The open question is whether the $8.6 billion quarterly guide lands and whether supply bottlenecks keep capping shipments and margin repair in the quarters ahead. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [LRCX.US](https://longbridge.com/en/quote/LRCX.US.md) - [LRCU.US](https://longbridge.com/en/quote/LRCU.US.md) ## Related News & Research - [Atlatl Advisers LLC Sells 14,564 Shares of Lam Research Corporation $LRCX](https://longbridge.com/en/news/302957118.md) - [Lam Research Corporation $LRCX Stock Sold by Valley National Advisers Inc.](https://longbridge.com/en/news/302985640.md) - [Lam Research (NASDAQ:LRCX) Releases Q2 2027 Earnings Guidance](https://longbridge.com/en/news/302904499.md) - [Generali Investments Management Co LLC Purchases 10,482 Shares of Lam Research Corporation $LRCX](https://longbridge.com/en/news/302279479.md) - [Lam Research (NASDAQ:LRCX) Shares Down 1% - What's Next?](https://longbridge.com/en/news/302612829.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**